Any current/future new fundraising through debt or equity?

There is no specific mention of any current or immediate future fundraising through debt or equity in the call. Nisha Dutt mentioned the possibility of increasing stake in subsequent rounds if needed, indicating potential for future equity fundraising depending on circumstances. The company is focused on stabilizing its capital table but is not actively pursuing M&A or fundraising opportunities at this time. Sumit Kumar highlighted regulatory hurdles for buybacks due to negative retained earnings, reflecting financial constraints. The management's priority currently is reinvesting internal fun

Any current/future capex/capital investment/strategic investment?

Current products are self-funded; no explicit mention of new external capital investment at the moment. Internal cash and funds are planned to be reinvested into existing businesses to drive next-level growth. New product developments are backed by internal IRR calculations to avoid cash burn from non-performing investments. Strategic investment example: Subex holds a 2.6% stake in Privasapien, a data privacy/AI company; no current plans to increase this stake. Focus remains on reinvesting internally identified opportunities rather than external investments. No active M&A pursuits currently, b

Future growth expectations in sales/revenue/volumes?

H1 FY26 was fairly good with a strong order book and profitability; momentum is expected to continue in H2, which usually performs slightly better than H1. Management aims to achieve INR 100 crore quarterly revenue, driven by a robust order book and faster deal conversions compared to previous years. Sales pipeline is actively managed with a target funnel of INR 180-200 million for the year, typically 4-5 times the order intake target. Approximately 20-30% of large multi-year orders convert into revenue within the first year, with the remainder spilling into future periods. Focus is on sustain

Current/ Expected Orderbook/ Pending Orders?

The exact order book as of November 1 is not disclosed publicly due to competitive sensitivity. The company operates on a backlog basis, with a stronger order book this year compared to last year, reflecting an uptick in order intake. Order funnel is internally tracked between INR 180 million to INR 200 million, indicating a pipeline 4-5 times the targeted annual order intake. Large orders typically range from 4 to 5 years, with about 20-30% revenue realization in the current year and the rest spilling over. Renewal orders maintain annuity revenue but don't contribute to growth. Mana

IN US

Sale is live|00:00:00left today

Subex LtdQ3 FY25IT - Software

Subex Ltd Q3 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹10.5P/E: 18.4Market Cap: ₹590 CrSector: IT - Software

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

Order

N/A

Capex

0 of 4 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3

→H1 FY26 was fairly good with a strong order book and profitability; momentum is expected to continue in H2, which usually performs slightly better than H1.
→Management aims to achieve INR 100 crore quarterly revenue, driven by a robust order book and faster deal conversions compared to previous years.
→Sales pipeline is actively managed with a target funnel of INR 180-200 million for the year, typically 4-5 times the order intake target.
→Approximately 20-30% of large multi-year orders convert into revenue within the first year, with the remainder spilling into future periods.
→Focus is on sustainable profitability and converting backlog into revenue rather than relying on one-time gains.
→Realistic revenue targets are always backed by a strong and diligently tracked sales funnel.
→Product enhancements include AI and GenAI native solutions aimed at lighter, faster deployments to unlock new industry segments.

Margin guidance

Category 3

- H1 FY26 was fairly good with a strong order book and profitability momentum. - H2 FY26 typically performs better than H1, and the company expects to continue this positive momentum. - Management aims to sustain positive PAT going forward, avoiding reliance on one-time gains. - Focus on reinvesting profits into business growth for the "next level" expansion. - Product development is primarily self-funded, with emphasis on AI and GenAI-native products. - Targets for revenue and order intake are backed by active pipelines and funnels monitored biweekly. - The company plans to share detailed product roadmaps and growth areas during the upcoming Investor Day. - There is cautious optimism for growth with ongoing deal conversions and some geographies picking up pace faster. - No active M&A currently, but stabilization of the cap table is a priority. Overall, Subex expects steady growth in earnings and profitability with improved pipeline conversion and strategic reinvestment.

3 more insights locked — sign up free to unlock

Fundraise plans

→There is no specific mention of any current or immediate future fundraising through debt or equity in the call.
→Nisha Dutt mentioned the possibility of increasing stake in subsequent rounds if needed, indicating potential for future equity fundraising depending on circumstances.
→The company is focused on stabilizing its capital table but is not actively pursuing M&A or fundraising opportunities at this time.
→Sumit Kumar highlighted regulatory hurdles for buybacks due to negative retained earnings, reflecting financial constraints.
→The management's priority currently is reinvesting internal funds into business growth rather than raising external capital.

Order book

→The exact order book as of November 1 is not disclosed publicly due to competitive sensitivity.
→The company operates on a backlog basis, with a stronger order book this year compared to last year, reflecting an uptick in order intake.
→Order funnel is internally tracked between INR 180 million to INR 200 million, indicating a pipeline 4-5 times the targeted annual order intake.
→Large orders typically range from 4 to 5 years, with about 20-30% revenue realization in the current year and the rest spilling over.
→Renewal orders maintain annuity revenue but don't contribute to growth.
→Management aims to reach INR 100 crore quarterly revenue, supported by the robust funnel and backlog.
→The company maintains confidentiality around orders due to the duopoly market and competitive concerns.
→New order visibility and forecasts are provided mainly through deal disclosures rather than detailed funnel breakdowns.

Capex plans

→Current products are self-funded; no explicit mention of new external capital investment at the moment.
→Internal cash and funds are planned to be reinvested into existing businesses to drive next-level growth.
→New product developments are backed by internal IRR calculations to avoid cash burn from non-performing investments.
→Strategic investment example: Subex holds a 2.6% stake in Privasapien, a data privacy/AI company; no current plans to increase this stake.
→Focus remains on reinvesting internally identified opportunities rather than external investments.
→No active M&A pursuits currently, but efforts to stabilize the capital table may lead to future strategic moves.
→Product roadmap includes making all products GenAI native and lighter to reduce heavy implementation cycles.

How does Subex Ltd rank vs peers in IT - Software?

Pro feature

1Subex Ltd

Rev 3Mar 3

See full IT - Software sector rankings

Want more stocks like Subex Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio